Close Menu

A Small Step

GlaxoSmithKline plans to open its labs to outside, nonprofit collaborators to spur research into malaria and other neglected diseases, Chief Executive Andrew Witty told Forbes. One such project for therapies to treat parasitic worms is being carried out in conjunction with Emory University researchers and Alnylam Pharmaceuticals. “GSK is providing us direct access to the scientists and all of the [internal] reports in the program. ...

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.